Freenome

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Lunit Inc. is a leading provider of AI-powered cancer screening and treatment solutions. The company's mission is to conquer cancer through AI by developing innovative technologies that can help detect and treat cancer earlier and more effectively. Lunit's AI solutions are used by hospitals and clinics around the world to improve the accuracy and efficiency of cancer diagnosis and treatment.

GRAIL is a healthcare company innovating to solve medicine’s most important challenges. Our team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it is more treatable and potentially curable. GRAIL's Galleri® test is a first-of-its-kind multi-cancer early detection (MCED) test that can detect a signal shared by more than 50 cancer types and predict the tissue type or organ associated with the signal to help healthcare providers determine next steps.

iCAD is an AI-powered application designed for cancer detection, specifically focusing on breast cancer. The platform offers a suite of solutions including Detection, Density Assessment, and Risk Evaluation, all backed by science, clinical evidence, and proven patient outcomes. iCAD's AI-powered solutions aim to expose the hiding place of cancer, providing certainty and peace of mind, ultimately improving patient outcomes and saving more lives.

Galleri is a multi-cancer early detection test that uses a single blood draw to screen for over 50 types of cancer. It is recommended for adults aged 50 or older who are at an elevated risk for cancer. Galleri is not a diagnostic test and does not detect all cancers. A positive result requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.

NeuProScan is an AI platform designed for the early detection of pre-clinical Alzheimer's from MRI scans. It utilizes AI technology to predict the likelihood of developing Alzheimer's years in advance, helping doctors improve diagnosis accuracy and optimize the use of costly PET scans. The platform is fully customizable, user-friendly, and can be run on devices or in the cloud. NeuProScan aims to provide patients and healthcare systems with valuable insights for better planning and decision-making.

HEALWELL AI is a healthcare technology company focusing on preventative care through AI and data science. Their mission is to improve healthcare and save lives by early disease detection. HEALWELL provides AI tools for healthcare providers to screen and detect rare, complex, and chronic diseases. They have developed AI clinical co-pilot technologies to assist physicians in early disease detection, ultimately accelerating time to diagnosis and saving lives.

Owkin is a full-stack AI biotech company that integrates the best of human and artificial intelligence to deliver better drugs and diagnostics at scale. By understanding complex biology through AI, Owkin identifies new treatments, de-risks and accelerates clinical trials, and builds diagnostic tools to reduce time to impact for patients.

Viz.ai is an AI-powered care coordination platform that helps providers improve patient outcomes. The platform uses advanced algorithms to analyze medical imaging data and provide real-time insights and automated assessments to accelerate diagnosis and treatment. Viz.ai's solutions are used by hospitals and health systems across the country to improve care for patients with a variety of conditions, including stroke, heart disease, and cancer.

Cleerly is a digital healthcare company transforming the way clinicians approach the treatment of heart disease. Our clinically-proven, AI-based digital care platform works with coronary computed tomography angiography (CCTA) imaging to help clinicians precisely identify and define atherosclerosis earlier, so they can provide personalized, life-saving treatment plans for all patients throughout their care continuum. We measure atherosclerosis - plaque build-up in the heart's arteries - not indirect markers such as risk factors and symptoms of disease. Our AI-enabled digital care pathway offers simpler, faster, more accurate heart disease evaluation and reporting that's tailored to each stakeholder, improving overall clinical and financial outcomes.

Iterative Health is a company that is dedicated to providing world-class GI care and treatment to patients around the world. They are on a mission to bring world-class care and treatment to patients around the world. Advances in machine learning and artificial intelligence are helping them create a complete GI ecosystem with the power to turn this vision into reality.

Oatmeal Health is an AI-powered lung cancer screening and diagnosis platform designed to help Federally Qualified Health Centers (FQHCs) identify high-risk patients, provide reimbursed lung cancer screenings, and share revenue without increasing the clinical team's workload. The platform uses AI-driven patient identification, virtual NPs and AI for screening and navigation, shared reimbursement revenue model, and research-backed innovation to advance early detection tools. Oatmeal Health aims to improve patient engagement, clinical efficiency, quality, compliance, and revenue impact for FQHCs, all at no cost implementation.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

The National Cancer Institute's Center for Biomedical Informatics and Information Technology (CBIIT) provides a comprehensive suite of tools, resources, and training to support cancer data science research. These resources include data repositories, analytical tools, data standards, and training materials. CBIIT also develops and maintains the NCI Thesaurus, a comprehensive vocabulary of cancer-related terms, and the Cancer Data Standards Registry and Repository (caDSR), a repository of cancer data standards. CBIIT's mission is to accelerate the pace of cancer research by providing researchers with the tools and resources they need to access, analyze, and share cancer data.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Galleri is a multi-cancer early detection test that uses a single blood draw to screen for over 50 types of cancer. It is recommended for adults aged 50 or older who are at an elevated risk for cancer. Galleri is not a diagnostic test and does not detect all cancers. A positive result requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.

GRAIL is a healthcare company innovating to solve medicine’s most important challenges. Our team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it is more treatable and potentially curable. GRAIL's Galleri® test is a first-of-its-kind multi-cancer early detection (MCED) test that can detect a signal shared by more than 50 cancer types and predict the tissue type or organ associated with the signal to help healthcare providers determine next steps.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

iCAD is an AI-powered application designed for cancer detection, specifically focusing on breast cancer. The platform offers a suite of solutions including Detection, Density Assessment, and Risk Evaluation, all backed by science, clinical evidence, and proven patient outcomes. iCAD's AI-powered solutions aim to expose the hiding place of cancer, providing certainty and peace of mind, ultimately improving patient outcomes and saving more lives.

RejuveAI is a decentralized token-based system that aims to democratize longevity globally. The Longevity App allows users to monitor essential health metrics, enhance lifespan, and earn RJV tokens. The application leverages revolutionary AI technology to analyze human body functions in-depth, providing insights for aging combat. RejuveAI collaborates with researchers, clinics, and data enthusiasts to ensure innovative outcomes are affordable and accessible. The platform also offers exclusive discounts on travel, supplements, medical tests, and longevity therapies.

NeuProScan is an AI platform designed for the early detection of pre-clinical Alzheimer's from MRI scans. It utilizes AI technology to predict the likelihood of developing Alzheimer's years in advance, helping doctors improve diagnosis accuracy and optimize the use of costly PET scans. The platform is fully customizable, user-friendly, and can be run on devices or in the cloud. NeuProScan aims to provide patients and healthcare systems with valuable insights for better planning and decision-making.

Insight is an AI-powered medical research tool that serves as a research assistant for generating scientific summaries, hypotheses, experimental designs, and target identification. It empowers scientists to navigate literature, formulate hypotheses, and design experiments by utilizing peer-reviewed databases to provide reliable outputs. With integrated features like NIH PubMed access, NIH Reporter insights, and MYGENE & MYVARIANT deep dives, Insight streamlines the research process and accelerates discoveries in the medical field.

Biofourmis is a healthcare technology company that provides a connected technology platform for care delivery and drug development. The platform enables healthcare systems and pharmaceutical companies to deliver care and conduct clinical trials remotely, and to collect and analyze data to improve patient outcomes. Biofourmis's solutions have been shown to improve clinical, operational, and economic outcomes, such as reducing 30-day readmissions by 70%, detecting deterioration 21 hours sooner, and reducing cost of care by up to 38%.

AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

CompliantChatGPT is a HIPAA-compliant platform that allows users to utilize OpenAI's GPT models for healthcare-related tasks while maintaining data privacy and security. It anonymizes protected health information (PHI) by replacing it with tokens, ensuring compliance with HIPAA regulations. The platform offers various modes tailored to specific healthcare needs, including bloodwork analysis, PHI anonymization, diagnosis assistance, and treatment planning. CompliantChatGPT streamlines healthcare tasks, enhances productivity, and provides user-friendly assistance through its intuitive interface.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Nucleai is an AI-driven spatial biomarker analysis tool that leverages military intelligence-grade geospatial AI methods to analyze complex cellular interactions in a patient's biopsy. The platform offers a first-of-its-kind multimodal solution by ingesting images from various modalities and delivering actionable insights to optimize biomarker scoring, predict response to therapy, and revolutionize disease diagnosis and treatment.

Mendel AI is an advanced clinical AI tool that deciphers clinical data with clinician-like logic. It offers a fully integrated suite of clinical-specific data processing products, combining OCR, de-identification, and clinical reasoning to interpret medical records. Users can ask questions in plain English and receive accurate answers from health records in seconds. Mendel's technology goes beyond traditional AI by understanding patient-level data and ensuring consistency and explainability of results in healthcare.

neurons.bio is an AI application that offers a unique collection of over 100 AI agents designed for drug development, medicine, and life science research. These agents perform specific tasks efficiently, retrieve data from various sources, and provide insights to accelerate research processes. The platform aims to revolutionize drug discovery and development by integrating cutting-edge LLM technology with domain-specific agents, reducing research costs and time to clinic.

IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

Ignota Labs is a technology company focused on rescuing failing drugs and bringing new life to abandoned projects, ultimately providing hope to patients. The company utilizes a proprietary AI model, SAFEPATH, which applies deep learning to bioinformatics and cheminformatics datasets to solve drug safety issues. Ignota Labs aims to identify promising drug targets, address safety problems in clinical trials, and accelerate the delivery of therapeutically effective drugs to patients.

Trially AI is a HIPAA-compliant AI clinical trial platform that leverages advanced technology to help life science leaders enroll qualified patients faster. The platform uses AI algorithms to unlock rich medical data, match patients to trials, and improve enrollment rates. Trially AI is proven to deliver superior results 4x faster than other technology providers, with features like multiplying enrollment, reducing screen fails, and increasing eligibility accuracy. It benefits sponsors, CROs, research sites, and hospitals by improving enrollment rates, saving time on chart reviews, and enhancing site success outcomes.

Steven Thompson is an AI HealthTech Leader specializing in Trial Orchestration. He builds systems that simplify complexity and lead teams to success, from large ERP programs to AI orchestration in clinical trials. The website showcases his expertise in compliance, scale, and human resilience, offering insights, case studies, and speaking engagements related to AI, trials, and ERP. Steven's approach emphasizes audit readiness, human-in-loop AI, and a focus on finishing strong. The site serves as a platform for industry leaders seeking transformation and measurable outcomes in their projects.

Formula Wizard is an AI-powered software designed to assist users in writing Excel, Airtable, and Notion formulas effortlessly. By leveraging artificial intelligence, the application automates the process of formula creation, allowing users to save time and focus on more critical tasks. With features like automating tedious tasks, unlocking insights from data, and customizing templates, Formula Wizard streamlines the formula-writing process for various spreadsheet applications.

Techscrunch.dev is a website that provides tech-related content and resources. It seems to be experiencing technical difficulties at the moment, as indicated by the error message displayed on the page. Users are advised to check their internet connection, proxy settings, and firewall to troubleshoot the issue. The site may offer articles, tutorials, and information on various tech topics, catering to tech enthusiasts, professionals, and learners.

Medallia is a real-time text analytics software that offers comprehensive feedback capture, role-based reporting, AI and analytics capabilities, integrations, pricing flexibility, enterprise-grade security, and solutions for customer experience, employee experience, contact center, and market research. It provides omnichannel text analytics powered by AI to uncover high-impact insights and enable users to identify emerging trends and key insights at scale. Medallia's text analytics platform supports workflows, event analytics, real-time actions, natural language understanding, out-of-the-box topic models, customizable KPIs, and omnichannel analytics for various industries.

LazyApply is an AI-powered job search tool that automates the job application process by applying to jobs across multiple platforms with a single click. It uses advanced AI algorithms to fill job applications based on user information and sends customized referral emails to relevant employees. The tool saves users hundreds of hours by streamlining applications and ensuring profiles never get blocked by platforms. LazyApply offers different plans to suit users' needs, with features like analytics dashboard, automated applications, and personalized autofill.

Suggest AI is a website created by @KShivendu that provides AI-related content and resources. It aims to help users understand and explore artificial intelligence technologies. The website offers a demo video for users to learn more about AI concepts and applications.

Talpa.ai is an AI-powered platform that offers advanced solutions for data analytics and automation. The platform leverages cutting-edge artificial intelligence technologies to provide businesses with valuable insights and streamline their operations. Talpa.ai helps organizations make data-driven decisions, optimize processes, and enhance overall efficiency. With its user-friendly interface and powerful features, Talpa.ai is a reliable partner for businesses looking to harness the power of AI for growth and success.

75 Wbet Com Daftar : OLX500 is an online platform offering a variety of casino games, including slots, live casino, poker, and more. Users can access popular games like Sweet Bonanza, Mahjong Ways, and Gates of Olympus. The platform also provides guidance on how to install the app on Android devices. With a focus on responsible gambling, 75 Wbet Com Daftar : OLX500 aims to enhance the gaming experience for its users.

Functime is an AI tool specializing in time-series machine learning at scale. It offers a comprehensive set of features and functions to assist users in forecasting and analyzing time-series data efficiently. With its user-friendly interface and detailed documentation, Functime is designed to cater to both beginners and experienced users in the field of machine learning. The tool provides scoring, ranking, and plotting functions to evaluate forecasts, along with an AI copilot feature for in-depth analysis of trends, seasonality, and causal factors. Functime also offers an API reference for seamless integration with other applications.

Knowledgio is a no-code solution for building personalized AI tools, designed for agencies and individuals looking to transform their expertise into unique AI applications. The platform allows users to save time by creating AI workspaces that can be easily shared and monetized. With a focus on simplicity and user-friendliness, Knowledgio enables non-technical users to build AI tools in minutes, leveraging features like easy data ingestion, automated distribution, and real-time collaboration. The platform supports multiple modalities such as text, voice, vision, and code, making it a versatile tool for a wide range of applications.

AIJ is an AI tool designed to streamline the job application process by automating tasks such as job searching, application submission, and answering frequently asked questions. Users can save time and energy by letting AIJ handle these tasks efficiently. The tool also allows users to correct AI mistakes, enabling continuous learning and improvement.